Browse 13366 Federal Education Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Education grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
November 16th, 2026 |
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) |
National Institutes of Health |
November 18th, 2026 |
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) |
National Institutes of Health |
May 3rd, 2024 |
U.S. Mission Turkiye, PD Annual Program Statement |
Bureau of European and Eurasian Affairs |
November 18th, 2026 |
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) |
National Institutes of Health |
November 15th, 2024 |
Effect of HIV and Substance Use Comorbidity on the Placenta and Maternal Outcomes (R01 Clinical Trial Optional) |
National Institutes of Health |
January 22nd, 2024 |
Established Program to Stimulate Competitive Research (EPSCoR) |
National Aeronautics and Space Administration |
November 27th, 2023 |
Tisamale Mabuku (Let us take care of books) Project |
Malawi USAID Lilongwe |
April 16th, 2024 |
Resource Center for Cannabis and Cannabinoid Research (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
February 1st, 2024 |
Fiscal Year (FY) 2024 AmeriCorps Seniors Senior Companion Program (SCP) Replacement and Expansion Opportunity |
AmeriCorps |
February 1st, 2024 |
Fiscal Year (FY 2024 AmeriCorps Seniors Foster Grandparents (FGP) Replacement and Expansion Opportunity Program |
AmeriCorps |
March 14th, 2024 |
Tools for decentralized clinical trials for substance use disorder (R43/R44 Clinical Trials Optional) |
National Institutes of Health |
March 14th, 2024 |
Tools for Decentralized Clinical Trials for Substance Use Disorder (R41/R42 Clinical Trials Optional) |
National Institutes of Health |
August 23rd, 2024 |
U.S. Consulate General Hong Kong and Macau, PAS |
US Mission to China |
February 20th, 2024 |
FY24 NOAA New England Bay Watershed Education and Training (B-WET) |
Department of Commerce |
January 7th, 2027 |
Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional) |
National Institutes of Health |
March 1st, 2024 |
Alaska Marine Education and Training Mini-Grant Program |
Department of Commerce |
March 13th, 2025 |
Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
March 13th, 2025 |
Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
February 8th, 2024 |
Applying Imaging Pipelines for Spatial Characterization of Cellular Interactions in HIV-related CNS Pathology and/or Substance Use (R61/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
December 18th, 2023 |
ROSS (Resident Opportunity and Self-Sufficiency) Service Coordinator Program - FY2023 - NOFO |
Department of Housing and Urban Development |
|
December 4th, 2024 |
Translational Research Toward Development of a Kaposi Sarcoma Herpesvirus (KSHV) Vaccine (U01 Clinical Trial Optional) |
National Institutes of Health |
January 6th, 2027 |
Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required) |
National Institutes of Health |
January 6th, 2027 |
Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed) |
National Institutes of Health |
October 13th, 2026 |
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
November 8th, 2023 |
Space Grant (SG) Quesst Community Overflight STEM Engagement (QCOSE) |
National Aeronautics and Space Administration |
January 16th, 2024 |
Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional) |
National Institutes of Health |
August 14th, 2025 |
Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
March 19th, 2025 |
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional) |
National Institutes of Health |
December 5th, 2023 |
Human Tumor Atlas (HTA) Research Centers (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
December 5th, 2023 |
Pre-Cancer Atlas (PCA) Research Centers (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
December 5th, 2023 |
Single Source: Human Tumor Atlas Network Data Coordinating Center (HTAN-DCC; U24 Clinical Trial Not Allowed) |
National Institutes of Health |
December 1st, 2023 |
Career Enhancement Award to Advance the Study of Intimate Partner Violence (IPV) in the Context of Maternal Morbidity and Mortality Research (K18 Clinical Trial Not Allowed) |
National Institutes of Health |
December 1st, 2023 |
R25 for Short Courses on Techniques for Measuring Intimate Partner Violence (IPV) in Different Populations (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2027 |
Advancing Research Careers (ARC) Predoctoral to Postdoctoral Transition Award to Promote Diversity (F99/K00 - Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2027 |
Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
August 14th, 2026 |
Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Clinical Trial Optional) |
National Institutes of Health |
August 14th, 2026 |
Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Basic Experimental Studies with Humans Required) |
National Institutes of Health |
December 20th, 2023 |
NOAA SBIR FY 2024 Phase I |
Department of Commerce |
August 14th, 2026 |
Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Clinical Trial Optional) |
National Institutes of Health |
March 13th, 2026 |
Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional) |
National Institutes of Health |